Esperion Therapeutics, Inc.
N/A
USD
N/A
N/A
...
Chart
Financials
Description
ESPR Company Description
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
ESPR Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view ESPR Smart Score
Score Breakdown
ESPR Company Description
Show More
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of ESPR by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by ESPR's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
Twitter
Followers on ESPR's company Twitter account
WallStreetBets
Number of mentions of ESPR in WallStreetBets Daily Discussion
ESPR News
Recent insights relating to ESPR
CNBC Recommendations
Recent picks made for ESPR stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in ESPR
Corporate Flights
Flights by private jets registered to ESPR
Our Analysis